SOLICITATION NOTICE
R -- Development of Inducible Point Mouse Line
- Notice Date
- 12/12/2012
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892
- ZIP Code
- 20892
- Solicitation Number
- RFQ2748426
- Archive Date
- 1/3/2013
- Point of Contact
- Idella M. Simpson, Phone: 301-435-8781
- E-Mail Address
-
simpsoi@nida.nih.gov
(simpsoi@nida.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items in accordance with the format in the Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation : proposals are being requested and a written solicitation will not be issued. This is not a small business set aside. This solicitation number is RFQ2800348 and a solicitation is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005- 63. The National Institute on Drug Abuse (NIDA), Station Support /Simplified Acquisition (SS/SA) Branch on behalf of the National Institute on Disorders and Stroke (NINDS) has a requirement for services. The Services will include the following: Bio-informatic analysis and cloning of the gene of interest: • Bioinformatic analysis, cloning and characterization of the gene of interest Construction of the targeting vector and designing of the screening strategy: • Design and construction of both the targeting vector and the positive control vector • Designing and setting up of the screening methodology ES cell transfection and homologous recombination: • Homologous recombination in ES cells and resistant clone isolation (400=400 c,ones) • Screening for homologous recombination (PCR and Southern Blot) ES Cell Blastocyct injection • ES cell blastocyst injection • Generation of chimeras Breeding to the F1 generation with wild type and FLP delete mice: • Breeding to the F1 generation and in vivo excision of the Neo cassette • Health monitoring of animals Quotations will be evaluated on the following criteria: Approach to the task Experience in development of inducible point mutant mouse lines Past Performance: Documented successful past performance of the stated services over the last 3 years. The anticipated period of performance is for one (1) year. Offerors will also be evaluated on best value in relation to price. Offerors must include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with its offer, Clause 52.212-4, Contract Terms and Conditions Commercial Items, applies to this acquisition. Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition. The quotations are due December 19, 2012, 12:00PM EST and will be submitted electronically to simpsoi@mail.nih.gov, Idella Simpson, Contract Specialist, 31 Center Drive Room 1B59, Bethesda, MD 20892.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/RFQ2748426/listing.html)
- Record
- SN02947335-W 20121214/121212234610-704d7fa5fd882ba46a6690bc31bd8479 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |